{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T02:25:00Z","timestamp":1775096700842,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 108-2314-B-002-155-MY3"],"award-info":[{"award-number":["MOST 108-2314-B-002-155-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["NTUH.110-T15"],"award-info":[{"award-number":["NTUH.110-T15"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.chest.2022.06.017","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T11:19:51Z","timestamp":1655983191000},"page":"1328-1337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Intravitreal Bevacizumab Is Associated With Prolonged Ventilatory Support in Preterm Infants With Bronchopulmonary Dysplasia"],"prefix":"10.1016","volume":"162","author":[{"given":"Cho-Yi","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-Chung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Huei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tso-Ting","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8932-9472","authenticated-orcid":false,"given":"Hung-Chieh","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-An","family":"Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wellington V.","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6114-1769","authenticated-orcid":false,"given":"Po-Nien","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.chest.2022.06.017_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1053\/j.semperi.2019.05.002","article-title":"Epidemiology of ROP update\u2014Africa is the new frontier","volume":"43","author":"Gilbert","year":"2019","journal-title":"Semin Perinatol"},{"issue":"7","key":"10.1016\/j.chest.2022.06.017_bib2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3928\/23258160-20170630-06","article-title":"The epidemiology of retinopathy of prematurity in the United States","volume":"48","author":"Ludwig","year":"2017","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"12","key":"10.1016\/j.chest.2022.06.017_bib3","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.chest.2022.06.017_bib4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.chest.2022.06.017_bib5","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ophtha.2017.09.020","article-title":"Foveal development in infants treated with bevacizumab or laser photocoagulation for retinopathy of prematurity","volume":"125","author":"Vogel","year":"2018","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.chest.2022.06.017_bib6","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.ophtha.2020.12.028","article-title":"Retinal detachment after treatment of retinopathy of prematurity with laser versus intravitreal anti-vascular endothelial growth factor","volume":"128","author":"Barry","year":"2021","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.chest.2022.06.017_bib7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ophtha.2016.12.025","article-title":"Anti-vascular endothelial growth factor therapy for primary treatment of type 1 retinopathy of prematurity: a report by the American Academy of Ophthalmology","volume":"124","author":"VanderVeen","year":"2017","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.chest.2022.06.017_bib8","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2005","article-title":"Hypotension associated with intravitreal bevacizumab therapy for retinopathy of prematurity","volume":"137","author":"Wu","year":"2016","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.chest.2022.06.017_bib9","doi-asserted-by":"crossref","first-page":"e20153218","DOI":"10.1542\/peds.2015-3218","article-title":"Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity","volume":"137","author":"Morin","year":"2016","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.chest.2022.06.017_bib10","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1167\/iovs.14-15842","article-title":"Pharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity","volume":"56","author":"Kong","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.chest.2022.06.017_bib11","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/IAE.0000000000001209","article-title":"Serum vascular endothelial growth factor after bevacizumab or ranibizumab treatment for retinopathy of prematurity","volume":"37","author":"Wu","year":"2017","journal-title":"Retina"},{"key":"10.1016\/j.chest.2022.06.017_bib12","doi-asserted-by":"crossref","first-page":"n1974","DOI":"10.1136\/bmj.n1974","article-title":"Diagnosis and management of bronchopulmonary dysplasia","volume":"375","author":"Gilfillan","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.chest.2022.06.017_bib13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41572-019-0127-7","article-title":"Bronchopulmonary dysplasia","volume":"5","author":"Thebaud","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"10.1016\/j.chest.2022.06.017_bib14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000381129","article-title":"Impaired pulmonary vascular development in bronchopulmonary dysplasia","volume":"107","author":"Baker","year":"2015","journal-title":"Neonatology"},{"issue":"10 pt 1","key":"10.1016\/j.chest.2022.06.017_bib15","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1164\/ajrccm.164.10.2109111c","article-title":"Bronchopulmonary dysplasia: \u201ca vascular hypothesis","volume":"164","author":"Abman","year":"2001","journal-title":"\u201dAm J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2022.06.017_bib16","doi-asserted-by":"crossref","first-page":"L36","DOI":"10.1152\/ajplung.00294.2011","article-title":"Excess soluble vascular endothelial growth factor receptor-1 in amniotic fluid impairs lung growth in rats: linking preeclampsia with bronchopulmonary dysplasia","volume":"302","author":"Tang","year":"2012","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"10.1016\/j.chest.2022.06.017_bib17","doi-asserted-by":"crossref","first-page":"L555","DOI":"10.1152\/ajplung.00408.2001","article-title":"Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure","volume":"283","author":"Le Cras","year":"2002","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"10.1016\/j.chest.2022.06.017_bib18","first-page":"121","article-title":"Acute and chronic effects of intravitreal bevacizumab on lung biomarkers of angiogenesis in the rat exposed to neonatal intermittent hypoxia","volume":"47","author":"Duggan","year":"2021","journal-title":"Exp Lung Res"},{"issue":"3","key":"10.1016\/j.chest.2022.06.017_bib19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/01902148.2017.1306897","article-title":"Intravitreal bevacizumab alters type IV collagenases and exacerbates arrested alveologenesis in the neonatal rat lungs","volume":"43","author":"Valencia","year":"2017","journal-title":"Exp Lung Res"},{"issue":"6","key":"10.1016\/j.chest.2022.06.017_bib20","doi-asserted-by":"crossref","first-page":"e20183061","DOI":"10.1542\/peds.2018-3061","article-title":"Screening examination of premature infants for retinopathy of Prematurity","volume":"142","author":"Fierson","year":"2018","journal-title":"Pediatrics"},{"issue":"12","key":"10.1016\/j.chest.2022.06.017_bib21","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/ppul.24487","article-title":"Short- and long-term respiratory outcomes in neonates with ventilator-associated pneumonia","volume":"54","author":"Dell\u2019Orto","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.chest.2022.06.017_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpeds.2019.04.020","article-title":"Echography-guided surfactant therapy to improve timeliness of surfactant replacement: a quality improvement project","volume":"212","author":"Raschetti","year":"2019","journal-title":"J\u00a0Pediatr"},{"issue":"8","key":"10.1016\/j.chest.2022.06.017_bib23","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1164\/rccm.201308-1499LE","article-title":"Heterogeneity in the definition of mechanical ventilation duration and ventilator-free days","volume":"189","author":"Contentin","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2022.06.017_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","article-title":"Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm","volume":"92","author":"Papile","year":"1978","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.chest.2022.06.017_bib25","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jpeds.2018.01.043","article-title":"Bronchopulmonary dysplasia: executive summary of a workshop","volume":"197","author":"Higgins","year":"2018","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.chest.2022.06.017_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51617-8","article-title":"Late-onset sepsis as a risk factor for bronchopulmonary dysplasia in extremely low birth weight infants: a nationwide cohort study","volume":"9","author":"Jung","year":"2019","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.chest.2022.06.017_bib27","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00228-012-1232-7","article-title":"Bevacizumab-induced serious side-effects: a review of the French pharmacovigilance database","volume":"68","author":"Taugourdeau-Raymond","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.chest.2022.06.017_bib28","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jjco\/hyu023","article-title":"Diffuse alveolar hemorrhage as a fatal adverse effect of bevacizumab: an autopsy case","volume":"44","author":"Ikeda","year":"2014","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.chest.2022.06.017_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.08.2010.3224","article-title":"Diffuse alveolar haemorrhage may be associated with intravitreal injection of bevacizumab in a patient with systemic risk factors","volume":"2011","author":"Seto","year":"2011","journal-title":"BMJ Case Rep"},{"issue":"5","key":"10.1016\/j.chest.2022.06.017_bib30","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/annonc\/mdr463","article-title":"Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts","volume":"23","author":"Reck","year":"2012","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.chest.2022.06.017_bib31","first-page":"1052","article-title":"Cutaneous lupus erythematosus in a patient undergoing intravitreal bevacizumab injections: case report and review of the literature","volume":"12","author":"Cleaver","year":"2013","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"3","key":"10.1016\/j.chest.2022.06.017_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3129\/i10-027","article-title":"Identifying systemic safety signals following intravitreal bevacizumab: systematic review of the literature and the Canadian Adverse Drug Reaction Database","volume":"45","author":"Micieli","year":"2010","journal-title":"Can J Ophthalmol"},{"issue":"4","key":"10.1016\/j.chest.2022.06.017_bib33","doi-asserted-by":"crossref","first-page":"F327","DOI":"10.1136\/archdischild-2012-302365","article-title":"Serious adverse events and visual outcomes of rescue therapy using adjunct bevacizumab to laser and surgery for retinopathy of prematurity. The Indian Twin Cities Retinopathy of Prematurity Screening Database report number 5","volume":"98","author":"Jalali","year":"2013","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"6","key":"10.1016\/j.chest.2022.06.017_bib34","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ophtha.2020.11.012","article-title":"Neurodevelopmental outcomes after bevacizumab treatment for retinopathy of prematurity: a meta-analysis","volume":"128","author":"Tsai","year":"2021","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.chest.2022.06.017_bib35","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jamaophthalmol.2020.0334","article-title":"Short-term outcomes after very low-dose intravitreous bevacizumab for retinopathy of prematurity","volume":"138","author":"Wallace","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.chest.2022.06.017_bib36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jamaophthalmol.2022.0030","article-title":"Plasma levels of bevacizumab and vascular endothelial growth factor after low-dose bevacizumab treatment for retinopathy of prematurity in infants","volume":"140","author":"Hartnett","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.chest.2022.06.017_bib37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12887-019-1610-8","article-title":"The discovery BPD (D-BPD) program: study protocol of a prospective translational multicenter collaborative study to investigate determinants of chronic lung disease in very low birth weight infants","volume":"19","author":"Ofman","year":"2019","journal-title":"BMC Pediatr"},{"issue":"2","key":"10.1016\/j.chest.2022.06.017_bib38","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2014.3676","article-title":"Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort","volume":"169","author":"Lapcharoensap","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.chest.2022.06.017_bib39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.chest.2021.01.079","article-title":"Association of bronchopulmonary dysplasia and right ventricular systolic function in young adults born preterm","volume":"160","author":"Dartora","year":"2021","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chest.2022.06.017_bib40","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.chest.2020.05.553","article-title":"Phenotypes of bronchopulmonary dysplasia in adults","volume":"158","author":"Cassady","year":"2020","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2022.06.017_bib41","doi-asserted-by":"crossref","first-page":"2000202","DOI":"10.1183\/13993003.00202-2020","article-title":"Early childhood respiratory morbidity and antibiotic use in ex-preterm infants: a primary care population-based cohort study","volume":"56","author":"Tan","year":"2020","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2022.06.017_bib42","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1513\/AnnalsATS.202107-822OC","article-title":"Meta-analysis of lung ultrasound scores for early prediction of bronchopulmonary dysplasia","volume":"19","author":"Pezza","year":"2022","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.chest.2022.06.017_bib43","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.chest.2021.02.066","article-title":"The predictive value of lung ultrasound scores in developing bronchopulmonary dysplasia: a prospective multicenter diagnostic accuracy study","volume":"160","author":"Alonso-Ojembarrena","year":"2021","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2022.06.017_bib44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1164\/rccm.201409-1594OC","article-title":"Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia","volume":"191","author":"Mourani","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.chest.2022.06.017_bib45","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1164\/rccm.202008-3131OC","article-title":"Lung ultrasound to monitor extremely preterm infants and predict bronchopulmonary dysplasia. A multicenter longitudinal cohort study","volume":"203","author":"Loi","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2022.06.017_bib46","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1146\/annurev.physiol.67.040403.102229","article-title":"Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia","volume":"67","author":"Stenmark","year":"2005","journal-title":"Annu Rev Physiol"},{"issue":"10","key":"10.1016\/j.chest.2022.06.017_bib47","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1164\/rccm.200611-1660PP","article-title":"Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease","volume":"175","author":"Thebaud","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.chest.2022.06.017_bib48","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1080\/14767058.2020.1760826","article-title":"Vascular endothelial growth factor levels and bronchopulmonary dysplasia in preterm infants","volume":"35","author":"Mariduena","year":"2022","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"5","key":"10.1016\/j.chest.2022.06.017_bib49","first-page":"480","article-title":"Vascular endothelial growth factor\/placental growth factor heterodimer levels in preterm infants with bronchopulmonary dysplasia","volume":"33","author":"Procianoy","year":"2016","journal-title":"Am J Perinatol"},{"issue":"4","key":"10.1016\/j.chest.2022.06.017_bib50","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000369878","article-title":"Prediction of respiratory outcome in extremely low gestational age infants","volume":"107","author":"Parad","year":"2015","journal-title":"Neonatology"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222011837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369222011837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:46:10Z","timestamp":1757925970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369222011837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0012369222011837"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2022.06.017","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal Bevacizumab Is Associated With Prolonged Ventilatory Support in Preterm Infants With Bronchopulmonary Dysplasia","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2022.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}